Jacquelyn Wiermaa is blazing the trail to help people find holistic solutions to encourage intrinsic healing to achieve health naturally.
Jacquelyn recently left the pediatric oncology program she developed when her final goal of bringing a Ronald McDonald House to the northland was achieved. She loved being a pediatric hematologist/oncologist, and the program she developed is going strong and provides a valuable resource to the community.
Traditional allopathic medical care no longer provides solutions to many of the health challenges people face today. Jacquelyn has made it her passion to bring holistic solutions to those who want natural options to promote health.
Children's Oncology Group
Jacquelyn arrived in Duluth in 2002 to build a pediatric oncology program. Part of this was having the Duluth program become an affiliate in the Children's Oncology Group, of which she was a member from 2000 to 2021. Jacquelyn held the role of a PI, principal investigator for the Duluth affiliate COG program, and oversaw the research involved in this program.
The Children’s Oncology Group (COG), a National Cancer Institute-supported clinical trials group, is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 10,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across North America, Australia, New Zealand, and Europe in the fight against childhood cancer.
Today, more than 90% of 16,000 children and adolescents diagnosed with cancer each year in the United States are cared for at Children’s Oncology Group member institutions. COG’s unparalleled collaborative efforts provide the information and support needed to answer critical clinical questions in the fight against cancer.
The Children’s Oncology Group has nearly 100 active clinical trials open at any time. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship.
The Children’s Oncology Group research has turned children’s cancer from a virtually incurable disease 50 years ago to one with a combined 5-year survival rate of 80% today.